Sato H - Search Results

1

Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices.

Aoki K, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sato h. Biol Pharm Bull. 2008 Oct;31(10):1882-7. doi: 10.1248/bpb.31.1882. Biol Pharm Bull. 2008. PMID: 18827348 Free article.

2

Role of CXC chemokines in the enhancement of LPS-induced neutrophil accumulation in the lung of mice by dexamethasone.

Aoki K, Ishida Y, Kikuta N, Kawai H, Kuroiwa M, Sato H. Aoki K, et al. Among authors: sato h. Biochem Biophys Res Commun. 2002 Jun 28;294(5):1101-8. doi: 10.1016/S0006-291X(02)00573-9. Biochem Biophys Res Commun. 2002. PMID: 12074590

3

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y. Shitara Y, et al. Among authors: sato h. J Pharmacol Exp Ther. 2003 Feb;304(2):610-6. doi: 10.1124/jpet.102.041921. J Pharmacol Exp Ther. 2003. PMID: 12538813

4

[Suppressive effect of erythromycin on LPS-induced NF-kappa B activation in mouse lung].

Aoki K, Kawai H, Sato H. Aoki K, et al. Among authors: sato h. Jpn J Antibiot. 2003 Apr;56 Suppl A:106-8. Jpn J Antibiot. 2003. PMID: 14679760 Japanese. No abstract available.

5

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil.

Shitara Y, Hirano M, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. J Pharmacol Exp Ther. 2004 Oct;311(1):228-36. doi: 10.1124/jpet.104.068536. Epub 2004 Jun 11. J Pharmacol Exp Ther. 2004. PMID: 15194707

6

In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats.

Shitara Y, Hirano M, Adachi Y, Itoh T, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Drug Metab Dispos. 2004 Dec;32(12):1468-75. doi: 10.1124/dmd.32.12.. Drug Metab Dispos. 2004. PMID: 15550721

7

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.

Shitara Y, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822193 Review.

8

Characterization of humanized liver from chimeric mice using coumarin as a human CYP2A6 and mouse CYP2A5 probe.

Aoki K, Kashiwagura Y, Horie T, Sato H, Tateno C, Ozawa N, Yoshizato K. Aoki K, et al. Among authors: sato h. Drug Metab Pharmacokinet. 2006 Aug;21(4):277-85. doi: 10.2133/dmpk.21.277. Drug Metab Pharmacokinet. 2006. PMID: 16946554 Free article.

9

[Analysis of students, achievement rate and contents of assessment for objective structured clinical examination (OSCE) attempted at the faculty of pharmaceutical sciences, Showa University].

Kogo M, Koyama N, Negoro T, Aoki K, Saito I, Kobayashi Y, Mashimo J, Sasaki K, Tobe T, Yamamoto T, Kiuchi Y, Sato H. Kogo M, et al. Among authors: sato h. Yakugaku Zasshi. 2007 May;127(5):905-17. doi: 10.1248/yakushi.127.905. Yakugaku Zasshi. 2007. PMID: 17473534 Free article. Japanese.

10

Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors.

Aoki K, Nakajima M, Hoshi Y, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sato h. Biol Pharm Bull. 2008 Mar;31(3):412-20. doi: 10.1248/bpb.31.412. Biol Pharm Bull. 2008. PMID: 18310902 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,853 results

Search Page